Global Oncology University ( GO-U)
Approaching “Global Oncology-Implementing Science” GOIS courses
14th session Wednesday January 31, 2024 , at 4.00-5.30 pm GMT
---------------------------------
- Repurposing and repositioning drugs and devices in cancer care
By: Prof. Ahmed Elzawawy,
-----------------------------------
-The opportunity for repurposed therapies in Low and Lower Middle Income Countries”.
By: Dr. Clare Thibodeaux , PhD, Vice President , Scientific Affaires , Cures Within Reach, USA
-----------------------------------
- Comments and suggestions & Q & A
Plus sending questions, comments and suggestions via e-mails & web
All your feedback and comments will be directed to the distinguished experts and co-leaders of GOIS
==================================
Distinguished Faculty presentation of the 14th Session:
Dr. Clare (Bennethum) Thibodeaux, PhD.
Vice President, Scientific Affairs at Cures Within Reach, USA
==================================
Distinguished Scientific Experts of the 14th session:
Prof. Eduardo L. Cazap MD, PhD, FASCO, Argentina , President & Founder -Latin-American & Caribbean Society of Medical Oncology (SLACOM) Co-Chair, Network of Latin American Cancer Institutes (RINC) .Past President - Union for International Cancer Control (UICC)
==================================
Professor David Kerr CBE MD PhD DSc FRCP FRCGP FACP FESMO FMedSci , UK : David contributes to Oxford as Professor of Cancer Medicine, where he has worked with colleagues to build a new Institute for Cancer Medicine and Cancer Hospital. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U. ==================================
Professor Karol Sikora, MA, MB BChir, PhD, MD, FRCR, FRCP, FFPM, UK , Consultant Oncologist, is the Medical Director of Cancer Partners International. He was the Founding Dean and now Professor of Medicine at Britain’s first independent Medical School at the University of Buckingham and a Fellow of Corpus Christi College, Cambridge. He was Professor and Chairman of the Department of Cancer Medicine at Imperial College School of Medicine and is still honorary Consultant Oncologist at Hammersmith Hospital, London. He was seconded to be Director of the WHO Cancer Programme in 2000. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, Co-founder, GO-U.
==================================
Clare Thibodeaux, PhD, Vice President, Scientific Affairs, Cures Within Reach, USA
Clare Thibodeaux, PhD is the Vice President, Scientific Affairs with Cures Within Reach , USA and has over 20 years of scientific research and philanthropic experience. Clare joined the Cures Within Reach team in November 2015, collaborating with a variety of repurposing stakeholders to catalyze repurposing research opportunities. Clare engages with key opinion leaders, research institution partners, industry representatives and patient advocates from any disease areas globally to identify, centralize and vet clinical repurposing research for funding. She is responsible for leading new scientific initiatives at Cures Within Reach, managing Cures Within Reach’s scientific grant outreach and review process, leading the Science Advisory Board and developing patient education events. Clare also serves on the Advisory Board for the Critical Path Institute’s CURE Drug Repurposing Collaboratory. She has led various committees and boards through her previous volunteer work with the American Cancer Society. Clare has advocated with state and federal elected officials concerning cancer related issues and educated the general public through community outreach. Prior to her involvement in the biomedical field, Clare was a market research professional. She holds a PhD in Tumor Biology from Georgetown University and an MBA from George Mason University.
=================================
Prof. Ahmed Elzawawy, MD, PhD, Founding Chair, win-win Scientific initiative & Co-founder & Chair, Board of Directors, GO-U & Global Oncology-Implementing Science Courses and program & Founding President, ICEDOC & Past President, AORTIC & Prof. Clinical Oncology, Suez Canal University &Chair. Clinical and Radiation Oncology Center , Port Said, Egypt.
==================================
Prof. Wilfred Ngwa, PhD, Dana-Farber/Harvard Cancer Center, University of Massachusetts Lowell, and Johns Hopkins University, USA. He is a distinguished professor of global public health, and distinguished professor of public health. He is founding Director of the Global Health Catalyst launched at the Harvard Radcliffe Institute in 2015 He currently chairs the Africa Health and Infrastructure Committee advising the USA government on Global Health. He is a co-founder (with Prof Ahmed Elzawawy and distinguished faculty) of Global Oncology University. Founder Director, GHC& Co-founder, GO-U. Co-Leader, The win-win initiative and Co-Director, Global Oncology-Implementing Science Courses and program, GO-U
==================================
Prof Cristina Stefan is a professor in medicine and global health, currently the President and CEO of the Medical Education Research and Innovation, adjunct professor at SingHealth Duke NUS Singapore and UMF University, Main, USA. PhD in medical education, MBA , France, MSc , Pediatrics and Oncology , South Africa, MSc cancer epidemiology , UK.
She was past President , AORTIC , She was voted as the most influential African woman in business and government (medicine) in 2016 , among the top 100 Women Leaders in Healthcare in Asia, in 2020. In 2022, she received IARC the (International Agency for Research in Cancer) award for women in cancer research.
A co-leader and distinguished faculty , The Global Oncology-implementing Science Program ( GOIS)
==================================
Prof. Twalib A. Ngoma , Prof. Clinical Oncology , Research Chair Holder Muhimbili University of Health and Allied Sciences MUHAS , Dar es Salaam, Tanzania. Co-Leader, The win-win initiative and Co-Founder, Global Oncology University GO-U
==================================
- Dr. Mrs. Beatrice Wiafe Addai, MD, PhD,
Consultant Breast Surgeon, C.E.O., Peace and Love Hospitals, Ghana
President and Founder, Breast Care International, Fmr Member, Ethics committee - IARC, Chairperson, Ghana Cancer Board, Medical Advisory Board Member, Direct Relief, Member, UICC.
==================================
An Acknowledgment to Dr. Manar Montasser, Clinical Oncologist, Department of Clinical Oncology and Nuclear Medicine , Suez Canal University , Ismailia, Egypt , for contribution in preparing the lecture
==================================
Further reading:
1. “ Approaching Global Oncology. The win-win model”
https://iopscience.iop.org/book/978-0-7503-3075-6 The first book summary (in front Matter) and the first chapter are free online.
& This session is based on Chapters 14, 15 , 23 , 24
& The next series of sessions is based on Chapters 14-24 & 35-36
2. The Win-Win Initiative. www.icedoc.org/winwin.htm and www.icedoc.net/winwin.htm
3. Elzawawy A. (2012). Science and Affordability of Cancer Drugs and Radiotherapy in the World - Win-Win Scenarios. In: Advances in Cancer Management, Ravinder Mohan (Ed.), InTech, Free access and download: https://www.intechopen.com/chapters/26808
======================
-How to join all sessions (It is for all GOIS sessions): please , Click on & register and Login in , Create an account –if you haven’t- fill the form, submit, you’ll receive an e-mail
https://icedoc.website/cms/mod/zoom/view.php?id=31
……………………………………..
- Or: Direct Zoom to this 14th session, on Wednesday 31th January, 2024 at 4.00-5.30 PM , GMT , Click on five minutes before the session: Join Zoom Meeting
https://us06web.zoom.us/j/83377986904?pwd=bnpZWLJ3gGDJAonbZC70HgtA0gOoVV.1
Meeting ID: 833 7798 6904
Passcode: 223976